Results 271 to 280 of about 112,335 (304)
Some of the next articles are maybe not open access.

Ivosidenib enhances cisplatin sensitivity in ovarian cancer by reducing cancer cell stemness

Cancer Drug Resistance
Aim: Cancer stem cells (CSCs) are pivotal in mediating platinum resistance in ovarian cancer. This study aimed to screen compounds sensitizing CSCs to cisplatin by using a small molecule inhibitor library.
Mengqing Chen   +9 more
semanticscholar   +1 more source

Identification of Novel HPK1 Hit Inhibitors: From In Silico Design to In Vitro Validation

International Journal of Molecular Sciences
Hematopoietic progenitor kinase 1 (HPK1), a negative regulator of T-cells, B-cells, and dendritic cells, has gained attention in antitumor immunotherapy research over the past decade.
Israa H. Isawi   +3 more
semanticscholar   +1 more source

Thiazolidinones as Potential PGK1 Inhibitors for Treatment of Osteosarcoma Growth and Metastasis.

Journal of Medicinal Chemistry
Osteosarcoma is one of the malignant bone tumors in children and adolescents. Due to unclear pathogenesis and lack of identified drug targets, there has been limited progress in developing targeted therapies in the past 50 years.
Xuwen Chen   +8 more
semanticscholar   +1 more source

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino   +2 more
exaly  

Targeted drug delivery strategies for precision medicines

Nature Reviews Materials, 2021
Mandana T Manzari   +2 more
exaly  

[Application of renal subcapsular assay to human malignant glioma--a new screening method in vivo for antitumoral drugs].

Gan to kagaku ryoho. Cancer & chemotherapy, 1985
H, Hamada   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy